Clinical Trial Update: The Effectiveness of Three Drug Combinations in HIV-Infected Patients Who Have Taken Zidovudine for More Than 12 Weeks [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating three drug combinations in HIV-infected patients with prior Zidovudine exposure (more than 12 weeks).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: COMPLETED